Related Experiment Video
Updated: Apr 10, 2026

20:28
A Toolkit to Enable Hydrocarbon Conversion in Aqueous Environments
Published on: October 2, 2012
14.7K
Systematic data-driven genome-scale metabolic model reduction for bioprocess modeling: CHO culture case study
Athanasios Antonakoudis1, Anne Richelle2
1Sartorius Corporate Research, Royston, UK.
NPJ Systems Biology and Applications
|April 8, 2026
Summary
We developed a new method to create smaller, more reliable metabolic models using experimental data. This approach improves dynamic bioprocess simulation and digital twin applications by accounting for data uncertainty.
Area of Science:
- Systems Biology
- Metabolic Engineering
- Biotechnology
Background:
- Genome-scale metabolic models (GEMs) offer mechanistic insights into cellular metabolism but are often too large and underdetermined for dynamic simulations.
- Existing model reduction methods struggle with experimental uncertainty, simplified rate estimations, or manual assumptions, limiting their robustness and scalability.
Purpose of the Study:
- To develop a novel, uncertainty-aware pipeline for reducing GEMs using metabolomics data.
- To generate compact GEMs suitable for dynamic bioprocess simulation and digital twin integration.
Main Methods:
- A metabolomics-driven reduction pipeline integrating Bayesian flux estimation to incorporate uncertainty from exo-metabolomics data.
- Application to time-course exo-metabolomics data from 12 fed-batch Chinese Hamster Ovary (CHO) cell cultures.
Main Results:
- A single reduced GEM was generated that remained feasible across all tested conditions.
- The reduced model accurately reproduced observed extracellular fluxes.
- The model preserved broad metabolic functionality despite relying solely on extracellular data.
Conclusions:
- The developed pipeline provides a systematic, uncertainty-aware framework for generating compact GEMs.
- This approach enhances the utility of GEMs for dynamic bioprocess simulation and digital twin applications.
- The method demonstrates the predictive power of extracellular metabolomics data for metabolic model reduction.
Related Concept Videos
Scale-Up Processes
86
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
86
Upstream Processing
84
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
84
Operon Model
2.2K
The operon model represents a fundamental mechanism of gene regulation in prokaryotes, enabling coordinated expression of genes involved in related metabolic or functional pathways. Operons consist of structural genes, a promoter, and an operator, with transcription regulated by repressors, activators, and small effector molecules.Structure and Function of OperonsAn operon is a cluster of structural genes transcribed together under the control of a single promoter. The promoter region...
2.2K
Bioreactor Controls-III
54
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
54
Biosynthesis in Bacteria
981
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
981
Pharmacokinetic Models: Comparison and Selection Criterion
462
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
462

